Skip to main content

Category: Infectious Diseases

  • david-wohl-headshot

    Need For COVID-19 Treatments Increases As NC Case Numbers Soar

    David Wohl, MD Even with multiple vaccines, people will continue to get sick from COVID-19. Treatments are needed to keep infected people from getting worse and inundating our hospitals even more. David Wohl, MD, professor of medicine in the division of infectious diseases, told CBS17 that UNC is investigating a testing treatment from Brii Bioscience, based in Durham. “The idea i … Read more

  • emily-sickbert-bennett-dom-newsworthy-January-2022

    Disinfecting Surfaces to Prevent COVID-19 May Be overkill, Expert Says

    Emily Sickbert-Bennett, PhD, MS Constantly disinfecting doorknobs and other everyday surfaces to prevent the spread of COVID-19 may be overkill, according to infectious disease experts. Emily Sickbert-Bennett, PhD, associate professor of medicine in the division of infectious diseases, told WTVD-11 that disinfecting all the surfaces in your house may not be a total waste of time … Read more

  • dr-jonathan-parr-STD-Awareness

    UK Approves Anti-inflammatory Drugs to Treat Sickest Covid-19 Patients After Strong Results in Clinical Trial

    Jonathan Parr, MD The Washington Post reports two rheumatoid arthritis drugs that suppress the immune system may help critically ill patients survive covid-19, providing a benefit even on top of the steroids that have been doctors’ main tools in treating the most serious cases of illness, according to a new study released Thursday before peer review. Jonathan Parr, MD, assistant … Read more

  • ‘Why I’m still alive’: A Patient’s Gratitude, Two Decades Later, Expressed To Dr. Becky White

    From left: Shani Morgan, Becky White, MD, and Shani’s son, Shakir In the summer of 2001, Shani Morgan was a few months pregnant and in prison, where she learned that she had HIV. She’d been sent from jail to Bragg Street Women’s Prison in Raleigh for better monitoring and medical treatment. What she remembers most about being treated by her UNC doctor, Becky White, MD, MPH, for H … Read more

  • CindyGay-newsworthy-nov-2021

    Gay Discusses Novavax Trials, Need For Diverse Participants

    Cindy Gay, MD, MPH A WTKR-News 3 story from northeastern North Carolina reports that UNC has begun enrolling participants for the Novavax COVID-19 vaccine phase III trial. Cindy Gay, MD, associate professor in the division of infectious diseases, describes the need for a diverse participation for the trial, including people over the age of 65, Black and Latino communities, and pe … Read more

  • ‘Why I’m still alive’: A patient’s gratitude, two decades later

  • David Wohl, MD-covid-newsworthy-january-14-20

    Releasing All COVID-19 Vaccine Doses to NC With Guarantee of Second Dose Is Big Promise to Keep

    David Wohl, MD CBS17 News reports that the Department of Health and Human Services announced Tuesday they would now ask states to stop holding back on COVID-19 vaccine doses. States were initially holding back doses to ensure that there would be enough for people come back for the recommended second dose. Federal public health officials said they hope this can help speed up the p … Read more

  • David Wohl, MD-covid-newsworthy-january-14-20

    Wohl Recognizes High Demand For Vaccine and Currently Limited Supply

    David Wohl, MD WTVD-11 reports UNC Health began administering COVID-19 vaccines to people 75 years of age and older under Phase 1B on Monday and that more health care providers in North Carolina are opening up vaccinations to those who qualify under Phase 1B. Already, existing appointments at UNC Health are booked, but David Wohl, MD, professor of medicine in the division of infe … Read more

  • joe-eron

    FDA Grants Emergency Use Authorization to Moderna Vaccine

    Joseph Eron, MD Joe Eron, MD, chief of the division of infectious diseases discussed the FDA’s approval of the Moderna COVID vaccine with WGN News Nation. He talked about his role as an investigator during the trials and recognized that both the Moderna and Pfizer vaccines are highly effective. He also emphasized the importance of getting people engaged and interested in receivin … Read more

  • December- Grants and Funding

    Department of Medicine Grants & Funding: December 1 – December 31, 2020

    Division of Hematology Nigel Mackman, PhD, FAHA, received an R35 grant from the National Heart Lung and Blood Institute of the NIH to fund the study “Tissue factor-dependent coagulation in thrombosis and immune responses.” Division of Infectious Diseases Jessica Lin, MD, MSCR, received an NIH National Institute of Allergy and Infectious Diseases R21 grant for “Plasmodium ovale hy … Read more

  • jonathan-serody

    Study Points the Way to Boosting Immunotherapy Effectiveness Against Breast Cancer and Other Solid Tumors

    Jonathan S. Serody, MD Boosting immune system T cells to effectively attack solid tumors, such as breast cancers, can be done by adding a small molecule to a treatment procedure called chimeric antigen receptor-T (CAR-T) cell therapy, according to a study by researchers at the UNC Lineberger Comprehensive Cancer Center. The boost helps recruit more immune cells into battle at the … Read more

  • CindyGay-newsworthy-nov-2021

    UNC Begins Enrollment for Novavax COVID-19 vaccine phase III clinical trial

    Cindy Gay, MD, MPH Cindy Gay, MD, associate professor of medicine in the division of infectious diseases, is leading the phase III clinical trial of the promising COVID-19 vaccine candidate for the UNC School of Medicine and UNC Medical Center. Gay, who also leads the UNC Moderna vaccine phase III clinical trial, says the work behind finding COVID-19 vaccines isn’t over. Learn mo … Read more